Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria

International Journal of Hematology

Volumn 75, Issue 2, 2002, Pages 117-122

  Kinoshita, Taroh ^a   Inoue, Norimitsu ^b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Aplastic anemia; Autoimmune disease; Hematopoietic stem cell; Paroxysmal nocturnal hemoglobinuria; Somatic mutation

Indexed keywords

APLASTIC ANEMIA; BLOOD CELL; BONE MARROW; CELL SELECTION; DISEASE ASSOCIATION; DISEASE COURSE; FLOW CYTOMETRY; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PHENOTYPE; REVIEW; SOMATIC MUTATION; SURVIVAL; CELL CLONE; GENETICS; HEMOLYSIS; PATHOLOGY;

MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL GLYCAN CLASS A PROTEIN; PHOSPHATIDYLINOSITOL GLYCAN-CLASS A PROTEIN;

ANEMIA, APLASTIC; CLONE CELLS; HEMOGLOBINURIA, PAROXYSMAL; HEMOLYSIS; HUMANS; MEMBRANE PROTEINS;

EID: 0036463495     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982015     Document Type: Review

References (51)

1. Lewis SM, Dacie JV. The aplastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome. Br J Haematol. 1967;13:236-251.
2. Tichelli A, Gratwohl A, Wursch A, Nissen C, Speck B. Late haematological complications in severe aplastic anaemia. Br J Haematol. 1988;69:413-418.
3. de Planque MM, Bacigalupo A, Wursch A, et al. Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT). Br J Haematol. 1989;73:121-126.
4. Najean Y, Haguenauer O. Long-term (5 to 20 years) evolution of nongrafted aplastic anemias. The Cooperative Group for the Study of Aplastic and Refractory Anemias. Blood. 1990;76:2222-2228.
5. Young NS, Maciejewski J. The pathophysiology of acquired aplastic anemia. N Engl J Med. 1997;336:1365-1372.
6. Young NS. Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia. Semin Hematol. 2000;37:3-14.
7. Rosse WF. New insights into paroxysmal nocturnal hemoglobinuria. Curr Opin Hematol. 2001;8:61-67.
8. Luzzatto L, Bessler M, Rotoli B. Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise? Cell. 1997;88:1-4.
9. Watanabe R, Murakami Y, Marmor MD, et al. Initial enzyme for glycosylphosphatidylinositol biosynthesis requires PIG-P and is regulated by DPM2. EMBO J. 2000;19:4402-4411.
10. 3-(4-azidoanilido)uridine 5′-triphosphate identifies Gpi3p as the UDP-GlcNAc-binding subunit of the enzyme that catalyses formation of GlcNAc-phosphatidylinositol, the first glycolipid intermediate in glycosylphosphatidylinositol synthesis. Biochem J. 2000;350:815-822.
11. Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993;73:703-711.
12. Nishimura J, Hirota T, Kanakura Y, et al. Long-term support of hematopoiesis by a single cell clone in patients with paroxysmal nocturnal hemoglobinuria. Blood. In press.
13. Terstappen L, Nguyen M, Huang S, Lazarus HM, Medof ME. Defective and normal haematopoietic stem cells in paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1993;84:504-514.
14. Yamada N, Miyata T, Maeda K, Kitani T, Takeda J, Kinoshita T. Somatic mutations of the PIG-A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood. 1995;85:885-892.
15. Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci U S A. 1999;96:5209-5214.
16. Kawagoe K, Kitamura D, Okabe M, et al. GPI-anchor deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria. Blood. 1996;87:3600-3606.
17. Rosti V, Tremmi G, Soares V, Pandolfi PP, Luzzatto L, Bessler M. Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J Clin Invest. 1997;100:1028-1036.
18. Murakami Y, Kinoshita T, Maeda Y, Nakano T, Kosaka H, Takeda J. Different roles of glycosylphosphatidylinositol in various hematopoietic cells as revealed by model mice of paroxysmal nocturnal hemoglobinuria. Blood. 1999;94:2963-2970.
19. Tremml G, Dominguez C, Rosti V, et al. Increased sensitivity to complement and a decreased red cell life span in mice mosaic for a non-functional Piga gene. Blood. 1999;94:2945-2954.
20. Keller P, Tremml G, Rosti V, Bessler M. X inactivation and somatic cell selection rescue female mice carrying a Piga-null mutation. Proc Natl Acad Sci U S A. 1999;96:7479-7483.
21. Keller P, Payne J L, Tremml G, et al. FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hamatopoietic stem cells in the bone marrow. J Exp Med. 2001;194:581-589.
22. Schubert J, Vogt HG, Zielinska Skowronek M, et al. Development of the glycosylphosphatidylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia. Blood. 1994;83:2323-2328.
23. Schrezenmeier H, Hertenstein B, Wagner B, Raghavachar A, Heimpel HA. Pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins. Exp Hematol. 1995;23:81-87.
24. Griscelli-Bennaceur A, Gluckman E, Scrobohaci ML, et al. Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link. Blood. 1995;85:1354-1363.
25. De Lord C, Tooze JA, Saso R, Marsh JCW, Gordon-Smith EC. Deficiency of glycosylphosphatidyl inositol-anchored proteins in patients with aplastic anaemia does not affect response to immunosuppressive therapy. Br J Haematol. 1998;101:90-93.
26. Azenishi Y, Ueda E, Machii T, et al. CD59-deficient blood cells and PIG-A gene abnormalities in Japanese patients with aplastic anaemia. Br J Haematol. 1999;104:523-529.
27. Dunn DE, Tanawattanacharoen P, Boccuni P, et al. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med. 1999;131:401-408.
28. Wang H, Chuhjo T, Yamazaki H, et al. Relative increase of granulocytes with a paroxysmal nocturnal haemoglobinuria phenotype in aplastic anaemia patients: the high prevalence at diagnosis. Eur J Haematol. 2001;66:200-205.
29. Mukhina GL, Buckley JT, Barber JP, Jones RJ, Brodsky RA. Multilineage glycosylphosphatidylinositol anchor-deficient haematopoiesis in untreated aplastic anaemia. Br J Haematol. 2001;115:476-482.
30. Nagarajan S, Brodsky RA, Young NS, Medof ME. Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia. Blood. 1995;86:4656-4661.
31. Rotoli B, Luzzatto L. Paroxysmal nocturnal haemoglobinuria. Baillieres Clin Haematol. 1989;2:113-138.
32. Young NS. The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated. Blood. 1992;79:1385-1392.
33. Young NS, Maciejewski JP. Genetic and environmental effects in paroxysmal nocturnal hemoglobinuria: this little PIG-A goes "Why? Why? Why?" J Clin Invest. 2000;106:637-641.
34. Karadimitris A, Luzzatto L. The cellular pathogenesis of paroxysmal nocturnal haemoglobinuria. Leukemia. 2001;15:1148-1152.
35. Hollander N, Selvaraj P, Springer TA. Biosynthesis and function of LFA-3 in human mutant cells deficient in phosphatidylinositol-anchored proteins. J Immunol. 1988;141:4283-4290.
36. Karadimitris A, Notaro R, Koehne G, Roberts IA, Luzzatto L. PNH cells are as sensitive to T-cell-mediated lysis as their normal counterparts: implications for the pathogenesis of paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2000;111:1158-1163.
37. - cells from the immunological attack. Paper presented at: International Symposium on PNH and Related Diseases; August 28-29, 2001; Tokyo, Japan.
38. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol. 2001;2:255-260.
39. Cosman D, Mullberg J, Sutherland CL, et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity. 2001;14:123-133.
40. Girardi M, Oppenheim DE, Steele CR, et al. Regulation of cutaneous malignancy by γδ T cells. Science. 2001;294:605-609.
41. Rammensee H-G, Friede T, Stevanovic S. MHC ligands and peptide motifs: first listing. Immunogenetics. 1995;41:178-228.
42. Joyce S, Woods AS, Yewdell JW, et al. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science. 1998;279:1541-1544.
43. Kawano T, Cui J, Koezuka Y, et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science. 1997;278:1626-1629.
44. Cerwenka A, Bakker ABH, McClanahan T, et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 2000;12:721-727.
45. Brodsky RA, Vala MS, Barber JP, Medof ME, Jones RJ. Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A. 1997;94:8756-8760.
46. Horikawa K, Nakakuma H, Kawaguchi T, et al. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome. Blood. 1997;90:2716-2722.
47. Ware RE, Nishimura J, Moody MA, Smith C, Rosse WF, Howard TA. The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria. Blood. 1998;92:2541-2550.
48. Bastisch I, Tiede A, Deckert M, Ziolek A, Schmidt RE, Schubert J. Glycosylphosphatidylinositol (GPI)-deficient Jurkat T cells as a model to study functions of GPI-anchored proteins. Clin Exp Immunol. 2000;122:49-54.
49. + stem cells in primary paroxysmal nocturnal hemoglobinuria. J Clin Invest. 2000;106:689-696.
50. Schrezenmeier H, Hildebrand A, Rojewski M, Hacker H, Heimpel H, Raghavachar A. Paroxysmal nocturnal haemoglobinuria: a replacement of haematopoietic tissue? Acta Haematol. 2000;103:41-48.
51. Lyakisheva A, Felda O, Ganser A, Schmidt RE, Schubert J. Paroxysmal nocturnal hemoglobinuria: differential gene expression of EGR-1 and TAXREB107. Exp Hematol. 2002;30:18-25.